| 영문 | amino acids | 한글 | 아미노산 |
|---|---|---|---|
| 설명 | 아미노기(－NH3)와 카르복실기(－COOH)를 가지고 있는 모든 유기물질. 단백질을 이루는 기본단위가 된다. 즉 단백질은 아미노산이 연결되어서 이루는 것이다. 인체에서는 아미노산이 단백질의 기본단위가 되는 것외에 신경세포와 신경세포가 서로 연락을 주고 받는데 쓰이는 신경전달물질로서의 역할도 한다. 사람의 단백질은 20가지의 아미노산으로 구성된다. 즉 사람에 있어서 단백질을 합성하는 데는 20가지의 아미노산이 필요하다. 여기에서 11가지는 인체내에서 직접 합성할 수 있지만 나머지 9가지는 합성할 수 없고 반드시 음식물에서 섭취해야 한다. 이것을 필수아미노산이라고 한다. |
||
| 영문 | total lung capacity | 한글 | 전폐용량, 온허파용량 |
|---|---|---|---|
| 설명 | 폐활량(가능한 한 깊게 들여 마신 시점부터 천천히 한껏 내쉰 용량)에 잔기량(최대 날숨위치에서 폐내에 남은 용량. 약 1,200mL)을 합한 것이다. 건강한 성인은 6,000~7,000mL. 폐기종, 만성 기관지염 등의 폐색성 장애로 증가하게 되는 한편 허파섬유증, 무기폐, 흉수, 흉곽변형 등의 구속성 장애로 감소한다. |
||
| TFA | total fatty acids; transverse fascicular area; triangular fibrocartilage; trifluoroacetic acid |
|---|---|
| TC | target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin... |
| VLCFA | Very Long Chain Fatty Acids |
| TBA | tertiary butylacetate; testosterone-binding affinity; tetrabutylammonium; thiobarbituric acid; to be... |
| TSBA | total serum bile acids |
| LCP | Long Chain Polyunsaturated fatty acids |
|---|---|
| LCFA | Long chain fatty acids |
| MCFA | Medium-chain fatty acids |
| MUFA | Monounsaturated fatty acids |
| SCFA | Short Chain Fatty Acids |
| monounsaturated fatty acids | A fatty acid chain with at least two empty spaces that could be hydrogenated (have a hydrogen atom added). Saturated (hydrogenated) fatty acids are a greater health risk for the development of atherosclerotic vascular disease. (27 Sep 1997) |
|---|---|
| saturated fatty acids | In eukaryotic membranes refers to stearic, palmitic and myristic acids, that are linear aliphatic chains with no double bonds. Prokaryotes have numerous branched chain saturated fatty acids. (18 Nov 1997) |
| omega 3 fatty acids | A class of fatty acids that have a double bond three carbons from the methyl moiety; reportedly, they play a role in lowering cholesterol and LDL levels. Synonym: omega-3 fatty acids. (05 Mar 2000) |
| fatty acids | Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (fatty acids, unsaturated). (12 Dec 1998) |
| fatty acids, essential | Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids. (12 Dec 1998) |
| fatty acids, monounsaturated | Fatty acids which are unsaturated in only one position. (12 Dec 1998) |
| fatty acids, nonesterified | The fraction of plasma fatty acids that are not in the form of glycerol esters. They are also called free fatty acids, but this is a misnomer because they are transported complexed with albumin. (12 Dec 1998) |
| fatty acids, omega-3 | A group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness. (12 Dec 1998) |
| fatty acids, unsaturated | Fatty acids containing one (monounsaturated) or multiple (polyunsaturated) double bonds. They predominate in most plant-derived fats. The number and position of each double bond can be specified, as in the systematic names, or the position of the double bond closest to the methyl group (omega) terminus can be specified to denote functional subdivisions of the overall group, e.g., omega-3 fatty acids. The numbers and positions of the double bonds have been linked to effects on plasma lipid, triglyceride, and cholesterol levels. (12 Dec 1998) |
| fatty acids, volatile | Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans. (12 Dec 1998) |
| radical mastectomy, total | Breast cancer treatment involving removal of the breast, the pectoral (chest) muscles, lymph nodes (the glands ) in the armpit and associated skin and subcutaneous tissue. (12 Dec 1998) |
| parenteral nutrition, home total | The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route. (12 Dec 1998) |
| parenteral nutrition, total | The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of tpn solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. (12 Dec 1998) |
| reversal of organs, total | This condition (medically called situs inversus totalis) involves complete transposition (right to left reversal) of the thoracic and abdominal organs. The heart is not in its usual position in the left chest but is on the right. Specifically related to the heart, this is referred to as dextrocardia (literally, right-hearted). And the stomach, which is normally in the left upper abdomen, is on the right. In patients with situs inversus totalis, all of the chest and abdominal organs are reversed and appear in mirror image when examined or visualised by tests such as X-ray filming. Situs inversus totalis has been estimated to occur once in about 6-8,000 births. Situs inversus occurs in a rare abnormal condition that is present at birth (congenital) called kartagener's syndrome. (12 Dec 1998) |
| communication methods, total | Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|